oral semaglutide cardiovascular outcomes soul trial results 2024 2025 nejm 💥Soul study group recently shared the New findings from the SOUL

The long-term effect of GLP-1 on retinopathy in patients with type 2 diabetes may in fact be beneficial

Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes

TSA guidelines say you can also keep needles and syringes in your checked suitcase

This reduces the risk of hypoglycaemia compared to some other diabetes medications, though this risk is increased when combined with insulin or sulfonylureas

Oral semaglutide , marketed under the brand name Wegovy, is the first and only FDA-approved GLP-1 pill for weight loss